<!DOCTYPE html>
<html lang="en">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1">
<title>Moe Capital</title>

	<style> 
		@media (prefers-color-scheme: dark){
		body {color:#fff;background:#000}
		a:link {color:#9cf}
		a:hover, a:visited:hover {color:#cef}
		a:visited {color:#c9f}
	}
	body{
		margin:1em auto;
		max-width:30em;
		padding:0 .62em;
		font:1.1em/1.2 Roboto,-apple-system,BlinkMacSystemFont,Helvetica Neue,Segoe UI,Oxygen,Ubuntu,Cantarell,Open Sans,Helvetica, Arial,sans-serif;		
		text-align:left;
		background: #001724;
		color: #f5f5f5;
	        letter-spacing: .01em;
		line-height: 1;
		
	}
	a {
             color: #ffdc09;
        }
	@media print{
		body{
			max-width:none
		}
	h1 {
		font-size:5rem;
	}
	h2 {
		font-size:3rem;
	}
	h3 {
		font-size:2rem;
	}
}
		</style>
<article>
	<header>
		<h1>Moe's US stock investing ideas </h1>
		</header>
	<p>
		Hello, We are Moe Capital and we provide market insights and help you invest wisely.
	</p>
	<p> We are popular as @MoneyAcademyKE on: <a href="https://twitter.com/MoneyAcademyKE" >Twitter</a>,
		<a href="https://t.me/MoneyAcademyKE" >Telegram</a> <a href="https://moneyacademy.substack.com/">Substack</a> and <a href="https://wa.me/+25469000111?text=I'm%20interested%20in%20your%20whatsapp%20news%20updates" >Whatsapp</a>
	</p>
		
	<p>ğ“ğ¡ğ¢ğ¬ ğ¢ğ¬ ğğğ“ ğˆğ§ğ¯ğğ¬ğ­ğ¦ğğ§ğ­ ğ€ğğ¯ğ¢ğœğ.</p>
	<p>Last update date:3rd June 2024</p>

        <div>
            <h3>Mastercard $MA</h3>
            <p>
                NTM P/E: 30.34x6 </br>
                5-Year Avg: 35.37x </br>
                Estimated EPS Growth 2025: 16.2%</br>
                Estimated EPS Growth 2026: 17.0%</br>
                LTM ROIC: 64.1%</br>
            
                </p>
            
            
            </div>

        <div>
            <h3>Salesforce $CRM</h3>
            <p>
NTM P/E: 23.30x</br>
5-Year Avg: 48.15x</br>
Estimated EPS Growth 2026*: 11.5%</br>
Estimated EPS Growth 2027*: 14.5%</br>
LTM ROIC: 9.1%</br>
                </p>
		<details>
    <summary>Salesforce valuation analysis </summary>
    <div>
NTM P/E Ratio: 23.30x</br>
â€¢3-Year Mean: 38.89x</br>

â€¢NTM FCF Yield: 5.18%</br>
â€¢3-Year Mean: 3.68%</br>

As you can see, $CRM appears to be trading below fair value</br>

Going forward, investors can expect to receive ~67% MORE in earnings per share & ~40% MORE in FCF per shareğŸ§ ***</br>

Before we get into valuation, letâ€™s take a look at why $CRM is a good business </br>

BALANCE SHEETâœ…</br>
â€¢Cash & Equivalents: $14.19B</br>
â€¢Long-Term Debt: $8.43B</br>

$CRM has an excellent balance sheet, an A+ S&P Credit Rating & 352x FFO Interest Coverage Ratio</br>

RETURN ON CAPITALğŸ†—</br>
â€¢2020: 1.2%</br>
â€¢2021: 0.9%</br>
â€¢2022: 0.8%</br>
â€¢2023: 2.5%</br>
â€¢2024: 8.2%</br>

RETURN ON EQUITYğŸ†—</br>
â€¢2020: 0.5%</br>
â€¢2021: 10.8%</br>
â€¢2022: 2.9%</br>
â€¢2023: 0.4%</br>
â€¢2024: 7.0%</br>

$CRM return metrics are ok, although more recently trending in the right direction</br>

REVENUESâœ…</br>
â€¢2014: $4.07B</br>
â€¢2024: $34.86B</br>
â€¢CAGR: 23.95%</br>

FREE CASH FLOWâœ…</br>
â€¢2014: $576.36M</br>
â€¢2024: $9.49B</br>
â€¢CAGR: 32.34%</br>

NORMALIZED EPSâœ…</br>
â€¢2014: $0.35</br>
â€¢2024: $8.22</br>
â€¢CAGR: 37.11%</br>

SHARE BUYBACKSâŒ</br>
â€¢2014 Shares Outstanding: 597.61M</br>
â€¢LTM Shares Outstanding: 984.00M</br>

By increasing its shares outstanding ~64%, $CRM diluted its EPS by ~39% (assuming 0 growth)</br>

MARGINSâœ…</br>
â€¢LTM Gross Margins: 75.5%</br>
â€¢LTM Operating Margins: 17.2%</br>
â€¢LTM Net Income Margins: 11.9%</br>

***NOW TO VALUATION ğŸ§ </br>

As stated above, investors can expect to receive ~67% MORE in EPS & ~40% MORE FCF per share </br>

Using Benjamin Grahamâ€™s 2G rule of thumb, $CRM has to grow earnings at an 11.65% CAGR over the next several years to justify its valuation</br>

Today, analysts anticipate 2025 - 2027 EPS growth over the next few years to be  slightly more than the (11.65%) required growth rate:</br>

2025E: $9.91 (20.5% YoY) *FY Jan</br>
2026E: $11.05 (11.5% YoY)</br>
2027E: $12.65 (14.5% YoY)</br>

$CRM has an excellent track record of meeting analyst estimates ~2 years out, so letâ€™s assume $CRM ends 2027 with $12.65 in EPS & see its CAGR potential assuming different multiples</br>

25x P/E: $316.25ğŸ’µ â€¦ ~12.5% CAGR</br>

24x P/E: $303.60ğŸ’µ â€¦ ~10.8% CAGR</br>

23x P/E: $290.95ğŸ’µ â€¦ ~9.1% CAGR</br>

As you can see, weâ€™d have to assume >24x earnings for $CRM to have double digit CAGR potential (a multiple justified by its growth rate & moat)</br>

Today at $234.44ğŸ’µ $CRM appears to be worthwhile consideration for investment especially when you assess the trajectory of the companyâ€™s FCF & Net Income margins (steadily trending higher with further room to expand)</br>

To ensure some margin of safety, if thereâ€™s further weakness, it could be wise to piece into the position, for example:</br>
</br>
Initiating ~50% of the position at ~$234ğŸ’µ & adding a second tranche at ~$200ğŸ’µ or at ~20x NTM earnings</br>
    </div>
</details>
            </div>
    <div>
            <h3>MoÃ«t Hennessy Louis Vuitton $LVMH</h3>
            <p>
NTM P/E: 22.21x</br>
5-Year Avg: 27.26x</br>
Estimated EPS Growth 2025: 11.3%</br>
Estimated EPS Growth 2026: 8.9%</br>
LTM ROIC: 21.0%</br>
                </p>
            </div>
    <div>
            <h3>Accenture $ACN</h3>
            <p>
NTM P/E: 22.84x</br>
5-Year Avg: 27.55x</br>
Estimated EPS Growth 2025: 8.6%</br>
Estimated EPS Growth 2026: 12.2%</br>
LTM ROIC: 32.3%</br>
                </p>
            </div>
    <div>
            <h3>UnitedHealth $UNH</h3>
            <p>
NTM P/E: 17.65x</br>
5-Year Avg: 19.72x</br>
Estimated EPS Growth 2025: 11.9%</br>
Estimated EPS Growth 2026: 12.9%</br>
LTM ROIC: 18.4%</br>
                </p>
            </div>

</article>
